| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 4 | |
| #2 | Brazil | 4 | |
| #3 | Canada | 4 | |
| #4 | Israel | 4 | |
| #5 | Republic of Korea | 4 | |
| #6 | Mexico | 4 | |
| #7 | Norway | 4 | |
| #8 | WIPO (World Intellectual Property Organization) | 4 | |
| #9 | South Africa | 4 | |
| #10 | Ecuador | 3 | |
| #11 | EPO (European Patent Office) | 2 | |
| #12 | EAPO (Eurasian Patent Organization) | 1 | |
| #13 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Specific use of cosmetics |
| # | Name | Total Patents |
|---|---|---|
| #1 | Weidner Morten Sloth | 30 |
| #2 | Wulff Hans Christian | 6 |
| #3 | Weider Morten Sloth | 5 |
| #4 | Sloth Weidner Morten | 4 |
| #5 | Wulff Hams Christian | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2015062611A1 | Compositions for dermatological use | |
| WO2007140791A1 | Treatment of cutaneous neurogenic inflammation | |
| EP1818058A2 | Treatment of mmp-mediated dermatological diseases with pemirolast | |
| WO2007093184A2 | Treatment of mmp-mediated dermatological diseases with pemirolast | |
| WO2007082542A1 | Compositions comprising oxaprozin and a vitamin d3 analogue and their use for the manufacture of a medicament for the treatment of psoriasis | |
| AU2006228869A1 | Oxaprozin or a closely related compound for the treatment of eczema |